Ozderya Aysenur, Temizkan Sule, Gul Aylin Ege, Ozugur Sule, Cetin Kenan, Aydin Kadriye
Department of Endocrinology and Metabolic Disorders, Kartal Dr. Lutfi Kirdar Training and Research Hospital, 34890, Istanbul, Turkey.
Department of Pathology, Kartal Dr. Lutfi Kirdar Training and Research Hospital, 34890, Istanbul, Turkey.
Ann Nucl Med. 2018 May;32(4):250-255. doi: 10.1007/s12149-018-1239-y. Epub 2018 Feb 5.
Technetium 99 m methoxyisobutylisonitrile (Tc-99m MIBI) scintigraphy represents the most commonly utilized imaging modality for the detection of the diseased gland in patients with primary hyperparathyroidism (PHPT). In this study, we aimed to identify potential biological factors with an impact on MIBI sensitivity.
A total of 147 patients with surgically confirmed parathyroid adenomas were assessed retrospectively. Data including medical history, biochemical and hormonal measurements, cervical US, Tc-99m MIBI scans as well as pathology reports were retrieved and recorded.
Of the 147 patients, there were a total of 77, 39, and 31 cases with a positive, negative, and suspicious parathyroid adenoma on Tc-99m MIBI scan, respectively. Serum calcium (Ca), parathyroid hormone (PTH) and 25 (OH) D levels were comparable among MIBI positive and negative patients [Ca: 11.5 ± 0.9 vs 11.3 ± 0.9 mg/dL (P = 0.42); PTH: 216 (146-347) vs 194 (140-317) pg/mL (P = 0.45); 25(OH)D: 8.4 (5.7-18.2) vs 10.0 (4.7-23.3) ng/mL (P = 0.64), respectively]. P-glycoprotein (P-gp) staining was negative in both groups. Also, pathological examination of tissue preparations revealed no difference in terms of the volume of the adenomas, incidence of cystic adenomas, cell-type dominance (oxyphilic cell), percent fat, and Ki-67 ratio in MIBI positive and negative groups. The rate of hyalinization was 13% in MIBI positive and 28% in MIBI negative subjects, the difference being statistically significant (P = 0.04).
Presence of hyalinization in parathyroid adenomas was found to be negatively correlated with MIBI scan results.
锝99m甲氧基异丁基异腈(Tc-99m MIBI)闪烁扫描术是检测原发性甲状旁腺功能亢进症(PHPT)患者病变腺体最常用的成像方式。在本研究中,我们旨在确定对MIBI敏感性有影响的潜在生物学因素。
对147例经手术证实患有甲状旁腺腺瘤的患者进行回顾性评估。收集并记录包括病史、生化和激素测量、颈部超声、Tc-99m MIBI扫描以及病理报告等数据。
在147例患者中,Tc-99m MIBI扫描显示甲状旁腺腺瘤阳性、阴性和可疑的病例分别有77例、39例和31例。MIBI阳性和阴性患者的血清钙(Ca)、甲状旁腺激素(PTH)和25(OH)D水平相当[Ca:11.5±0.9 vs 11.3±0.9mg/dL(P = 0.42);PTH:216(146 - 347)vs 194(140 - 317)pg/mL(P = 0.45);25(OH)D:8.4(5.7 - 18.2)vs 10.0(4.7 - 23.3)ng/mL(P = 0.64)]。两组P-糖蛋白(P-gp)染色均为阴性。此外,组织标本的病理检查显示,MIBI阳性和阴性组在腺瘤体积、囊性腺瘤发生率、细胞类型优势(嗜酸性细胞)、脂肪百分比和Ki-67比率方面无差异。MIBI阳性患者的玻璃样变率为13%,MIBI阴性患者为28%,差异具有统计学意义(P = 0.04)。
发现甲状旁腺腺瘤中玻璃样变的存在与MIBI扫描结果呈负相关。